The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Life Insurance Corporation of India (LIC) has disclosed a market purchase of 2,00,000 equity shares (0.019%) of Zydus Lifesciences on August 1, 2025. This acquisition increased LIC's total holding from 5,01,19,995 shares (4.981%) to 5,03,19,995 shares, taking its stake to exactly 5.000% of the company's share capital. The disclosure was filed under Regulation 29(1) of SEBI's Takeover Regulations, triggered because LIC crossed the 5% substantial shareholder threshold. LIC clarified it does not belong to the promoter or promoter group of the company.
This is a routine regulatory disclosure triggered by LIC marginally crossing the 5% threshold; the small purchase size (0.019%) is unlikely to materially impact share price but confirms LIC as a significant institutional holder of Zydus Lifesciences.